Patients should be aware of symptoms such as severe abdominal pain, an inability to pass gas, or difficulty moving bowels and seek immediate medical attention if these occur
If you are taking a GLP-1 medication and are considering discontinuing it, you should first speak with your healthcare professional
Its stable, has a long history of use in pharmaceuticals, and effectively inhibits the growth of most common contaminants without significantly interacting with the compounds its meant to preserve
Patients should verify current availability, applicable compounding pathway, and regulatory status directly with Eden and with a licensed healthcare professional before enrolling in any compounded GLP-1 program
GC18256 PF-06281355 PF-06281355 PF-06281355 is a selective 2-thiouracil mechanism-based MPO inhibitor, used for treatment of vasculitic diseases